The unfolding pathway and conformational stability of potato carboxypeptidase inhibitor

被引:33
作者
Chang, JY
Li, L
Canals, F
Aviles, FX
机构
[1] Univ Texas, Inst Mol Med, Res Ctr Prot Chem, Houston, TX 77030 USA
[2] Univ Autonoma Barcelona, Dept Bioquim, Bellaterra 08193, Spain
[3] Univ Autonoma Barcelona, Inst Biol Fonamental, Bellaterra 08193, Spain
关键词
D O I
10.1074/jbc.275.19.14205
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The unfolding and denaturation curves of potato carboxypeptidase inhibitor (PCI) were investigated using the technique of disulfide scrambling. In the presence of denaturant and thiol initiator, the native PCI denatures by shuffling its native disulfide bonds and converts to form a mixture of scrambled PCI that consists of 9 out of a possible 14 isomers. The denaturation curve is determined by the fraction of native PCI converted to scrambled isomers under increasing concentrations of denaturant. The concentration of guanidine thiocyanate, guanidine hydrochloride, and urea required to denature 50% of the native PCI was found to be 0.7, 1.45, and 8 M, respectively. The PCI unfolding curve was constructed through the analysis of structures of scrambled isomers that were denatured under increasing concentrations of denaturant. These results reveal the existence of structurally defined unfolding intermediates and a progressive expansion of the polypeptide chain. The yield of the beads-form isomer (Cys(8)-Cys(12), Cys(18)-Cys(24), and Cys(27)-Cys(34)) as a fraction of total denatured PCI was shown to be directly proportional to the strength of the denaturing condition. Furthermore, the PCI sequence was unable to fold quantitatively into a single native structure, Under physiological conditions, the scrambled isomers of PCI that constitute about 4% of the protein were in equilibrium with native PCI.
引用
收藏
页码:14205 / 14211
页数:7
相关论文
共 41 条
[1]  
Aguzzi A, 1999, LANCET, V354, pSI22
[2]  
ALEXANDRESCU AT, 1995, BIOCHEMISTRY-US, V33, P1036
[3]   Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth [J].
Blanco-Aparicio, C ;
Molina, MA ;
Fernández-Salas, E ;
Frazier, ML ;
Mas, JM ;
Querol, E ;
Avilés, FX ;
de Llorens, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (20) :12370-12377
[4]   THE NEW BIOLOGY OF SPONGIFORM ENCEPHALOPATHY - INFECTIOUS AMYLOIDOSES WITH A GENETIC TWIST [J].
BROWN, P ;
GOLDFARB, LG ;
GAJDUSEK, DC .
LANCET, 1991, 337 (8748) :1019-1022
[5]   Unfolding of hirudin characterized by the composition of denatured scrambled isomers [J].
Bulychev, A ;
Chang, JY .
JOURNAL OF PROTEIN CHEMISTRY, 1999, 18 (07) :771-778
[6]   Quantitative analysis of the composition of the native and scrambled ribonuclease A [J].
Chang, JY .
ANALYTICAL BIOCHEMISTRY, 1999, 268 (01) :147-150
[7]   Denatured states of tick anticoagulant peptide - Compositional analysis of unfolded scrambled isomers [J].
Chang, JY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :123-128
[8]  
CHANG JY, 1994, J BIOL CHEM, V269, P22087
[9]  
Chang JY, 1997, J BIOL CHEM, V272, P69
[10]   The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI [J].
Chang, JY .
BIOCHEMISTRY, 1996, 35 (36) :11702-11709